AbCellera Biologics Ownership | Who Owns AbCellera Biologics?
AbCellera Biologics Ownership Summary
AbCellera Biologics is owned by 38.62% institutional investors, 23.07% insiders, and 38.31% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 9.34% of ABCL shares. American Funds SMALLCAP World A is the top mutual fund, with 4.48% of its assets in AbCellera Biologics shares.
ABCL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | AbCellera Biologics | 38.62% | 23.07% | 38.31% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 27.53M | 9.34% | $80.65M |
| Baillie gifford | 12.24M | 4.15% | $35.85M |
| Voya investment management | 10.62M | 3.60% | $31.13M |
| Capital world investors | 7.93M | 2.69% | $23.25M |
| Prosight management, lp | 7.35M | 2.49% | $21.54M |
| Ubs asset management americas | 4.50M | 1.53% | $13.19M |
| Orbimed advisors | 4.18M | 1.42% | $12.25M |
| Arrowmark colorado | 4.11M | 1.39% | $12.03M |
| Blackrock funding, inc. /de | 4.10M | 1.39% | $12.00M |
| Blackrock | 3.80M | 1.30% | $11.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Prosight management, lp | 7.35M | 5.95% | $21.54M |
| Baker bros. advisors lp | 27.53M | 0.86% | $80.65M |
| Guardian partners | 1.79M | 0.55% | $5.41M |
| Guardian capital advisors lp | 1.79M | 0.53% | $5.00M |
| Tang capital management | 2.58M | 0.50% | $7.57M |
| Opaleye management | 965.00K | 0.49% | $2.83M |
| Intellectus partners | 547.53K | 0.36% | $1.60M |
| Orbimed advisors | 4.18M | 0.25% | $12.25M |
| Entrypoint capital | 168.68K | 0.21% | $494.24K |
| Novo | 1.13M | 0.20% | $3.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 7.93M | 0.00% | 7.93M |
| Ubs group | 1.98M | 0.00% | 1.95M |
| Guardian partners | 1.79M | 0.55% | 1.79M |
| Norges bank | 1.28M | 0.00% | 1.28M |
| Millennium management | 1.48M | 0.00% | 728.83K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Founders fund vii management | - | - | -3.77M |
| Casdin capital | - | - | -2.36M |
| Prosight management, lp | 7.35M | 5.95% | -1.73M |
| Federated hermes | 916.24K | 0.01% | -1.37M |
| Man group | - | - | -771.93K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Guardian partners | 1.79M | 0.55% | 1.79M | $5.41M |
| Norges bank | 1.28M | 0.00% | 1.28M | $3.76M |
| Exoduspoint capital management, lp | 281.80K | 0.01% | 281.80K | $826.00K |
| Peak6 | 200.00K | 0.00% | 200.00K | $585.99K |
| Graham capital management | 103.61K | 0.00% | 103.61K | $303.58K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -46.00 |
| Morton brown family wealth | -75.00 |
| Atticus wealth management | -100.00 |
| Bell investment advisors | -136.00 |
| Cva family office | -339.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 147 | 2.80% | 113,857,437 | 8.74% | 38 | 3.06% | 69 | -4.17% | 39 | 18.18% |
| Sep 30, 2024 | 140 | -8.50% | 104,569,721 | -8.52% | 35 | 2.33% | 70 | 20.69% | 34 | -29.17% |
| Jun 30, 2024 | 153 | -4.38% | 114,320,602 | -4.79% | 39 | 2.28% | 59 | -21.33% | 47 | 9.30% |
| Mar 31, 2024 | 160 | 5.26% | 120,076,236 | 0.81% | 41 | 2.45% | 75 | 1.35% | 43 | 13.16% |
| Dec 31, 2023 | 152 | 4.11% | 119,116,483 | 0.07% | 41 | 2.42% | 74 | 32.14% | 38 | -2.56% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 13.36M | 4.48% | 5.43M |
| Allianz Global Artfcl Intlgc W EUR | 6.13M | 2.06% | 31.13K |
| SMDS Global AI Equity Mother | 4.49M | 1.52% | - |
| Baillie Gifford Positive Change B Acc | 4.53M | 1.52% | 14.78K |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 4.50M | 1.51% | - |
| UBS (Lux) Digital Health Equity SB USD | 4.50M | 1.51% | - |
| Baillie Gifford Positive Change | 4.49M | 1.51% | - |
| American Funds IS® Asset Allocation 1 | 2.87M | 0.97% | - |
| Baillie Gifford WW Pstv Chg B USD Acc | 2.52M | 0.85% | -118.04K |
| iShares Biotechnology ETF | 1.43M | 0.48% | -15.93K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 11, 2025 | Thermopylae Holdings Ltd. | - | Buy | $742.24K |
| Mar 10, 2025 | Montalbano John S. | - | Buy | $57.50K |
| Mar 06, 2025 | Montalbano John S. | - | Buy | $140.57K |
| Aug 29, 2024 | Thermopylae Holdings Ltd. | - | Buy | $739.98K |
| Nov 06, 2023 | Montalbano John S. | - | Buy | $92.80K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 3 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 1 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
ABCL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools